Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
FLUOXETINE
Dr. Reddy's Laboratories (UK) Ltd
60 Milligram
Capsules Hard
2008-10-03
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Fluoxetine 60mg Hard Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 60 mg of fluoxetine (as hydrochloride) Each capsule also contains the colouring agents, Tartrazine (E102) [0.37mg] and Sunset Yellow FCF (E110) [0.0009mg]. For a full list of excipients, see Section 6.1 3 PHARMACEUTICAL FORM Capsule, Hard Hard gelatin capsules with yellow cap and white body imprinted with ‘FLX’ on cap and ‘60’ on body with black ink. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Major depression Obsessive-compulsive disorder Bulimia nervosa: fluoxetine is indicated as a complement to psychotherapy for reduction of binge eating and purging activity. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For oral administration to adults only _Major depression _– Adults and the elderly: the recommended dose is 20mg daily. Dosage should be reviewed and adjusted if necessary within 3 to 4 weeks of initiation of therapy and thereafter as judged clinically appropriate. Although there may be increased potential for undesirable effects at higher doses in some patients with insufficient response to 20 mg, the dose may be increased gradually up to a maximum of 60 mg (see section 5.1). Dosage adjustments should be made carefully on an individual patient basis, to maintain the patients at the lowest effective dose. Patients with depression should be treated for a sufficient period of at least 6 months to ensure that they are free from symptoms. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 17/02/2012_ _CRN 2085601_ _page number: 1_ _Obsessive-compulsive disorder – _Adults and the elderly: the recommended dose is 20mg dai Read the complete document